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High Resolution Nuclear Magnetic Resonance Studies 
of the Active Site of Chymotrypsin 
II. Polarization of Hi&dine 57 by Substrate Analogues 
and Competitive Inhibitors 
G. ROBILLABD AND R. G. SHULMU 
Bell Laboratories, Murray Hill, N.J. 07974, U.S.A. 
(Received 29 January 1974) 
The proton nuclear magnetic resonance signal of the His57-Asp102 hydrogen 
bonded proton in the charge relay system of chymotrypsinogen A and ohymo- 
trypsin Aa has been monitored to determine the influence of substrate analogues 
and competitive inhibitors on the electronic state of the active site regions. 
Borate ion, benzene boronic acid and 2-phenylethylboronic acid, when bound 
to chymotrypsin at pH 9.5 shift the resonance position of the His-Asp hydrogen 
bonded proton to -159, -16.3 and -17.2 parts per million, respectively. 
These positions are intermediate between the low pH position in the free enzyme 
of - 18.0 parts per million and the high pH position of - 14.9 parts per million. 
The presence of these analogues prevents the His-Asp proton resonance from 
titrating in the region of pH 6 to 9.5. Similar low field shifts are observed for the 
hydrogen bonded proton resonance of subtilisin BPN’ when complexed with 
these boronic acids. The results support the chemical and crystallographic data 
which show that negatively charged tetrahedral adducts of the boronic acid 
substrate analogues are formed at the active sites of these enzymes. When 
combined with similar nuclear magnetic resonance data for the binding of N- 
acetyl-L-tryptophan to chymotrypsin Ad, they suggest that a direct interaction 
occurs between the active site histidine and the atom occupying the leaving 
group position of the substrate, presumably a hydrogen bond. 
The His-Asp proton resonance was also monitored in complexes of chymo- 
trypsin Ad with bovine pancreatio trypsin inhibitor over the pH range 4 to 9. 
In the complex the low field proton resonance had a field position of - 14.9 
parts per million over the pH range 4 to 9 indicating that His57 is in the neutral 
form, similar to the active enzyme at high pH. 
1. Introduction 
Nuclear magnetic resonance studies of the hydrogen bonded protons at the active 
site of chymotrypsin Ad and in the same region of chymotrypsinogen A have recently 
been reported (Robillard & Shulman, 1972,1974) as part of an effort to determine the 
impact of the “charge relay” system on the overall catalytic activity of the serine ester- 
ase (Blow et a.!., 1969). Using high resolution n.m.r.t at 220 MHz a resonance from 
an exchangeable proton was observed at extremely low fields for H,O solutions of 
chymotrypsinogen A, chymotrypsin A&, trypsinogen, trypsin, subtilisin BPN and 
a-lytic protease. Detailed n.m.r. studies of this resonance in chymotrypsinogen A 
and chymotrypsin Ad, including covalent chemical modifications of the protein, 
t Abbreviation8 used: n.m.r., nuclear magnetic resonance; YTI, panoreatic trypsin inhibitor. 
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has enabled us to assign this resonance to the proton on the N(1) nitrogen of His57 
which is in a strong hydrogen bond with the carboxylate of Asplo2. In the same 
study we demonstrated that the N(3) nitrogen of His57 is also hydrogen bonded to 
the hydroxyl group of the active site Ser195, thereby supporting the existence of 
the charge relay system proposed by Blow et al. (1969). 
In the present paper we report the response of the same low field proton resonance 
to competitive inhibitors and substrate analogues bound at the active site of chymo- 
trypsin. It is well known that boronic acid substrate analogues and borate ions bind 
reversibly to chymotrypsin (Antonov et al., 1968,197O; Philipp & Bender, 1971; 
Koehler & Lienhard, 1971). Their strong association constants were the first indica- 
tion that they were bound at the active site as tetrahedral transition state analogues. 
This proposal has recently been supported by X-ray crystallographic studies 
on subtilisin-boronic acid complexes (Birktoft & Kraut, personal communication). 
Furthermore, the X-ray studies show that one of the boron oxygens is close enough 
to form a hydrogen bond with the N(3) nitrogen of His57. Similar X-ray crystal- 
lographic observations have been made for the complexes of chymotrypsin with N- 
formyl-1;-tryptophan and N-formyl-L-phenylalanine in which one of the carboxylate 
oxygens is within hydrogen bond distance of the same nitrogen of His57 (Steitz et al., 
1969). Presumably this atom occupies a position analogous to the amide leaving 
group of a conventional peptide substrate. 
Interactions between charged groups on the substrate and the imidazole ring of 
His57 should perturb the electron distribution of this ring which should shift the 
proton resonance at the N(1) position. Such perturbations have been observed and 
are reported below. They are interpreted in terms of the function of the charge relay 
system during the catalytic pathway. 
2. Materials and Methods 
(a) Muterid 
Enzyme. Bovine chymotrypsinogen A and bovine chymotrypsin Aa (code CGC and 
CDD, respectively) were purchased from Worthington Biochemicals ; bovine pancreatic 
trypsin inhibitor (type 1-P) waa purchased from Sigma Chemicals and used without 
further puriflcetion. Subtilisin BPN’ (Nagarse) was purchased from Enzyme Develop- 
ment Corporation, 2 Penn Plaza, New York, N.Y. It was dissolved in 0.01 M-C&l,, 
pH 6, end chromatographed on a column of Sephadex G76 in 0.01 rvr-CaClz, pH 6, at 
6°C and lyophilized immediately. 2-Phenylethyl boronic acid was generously supplied 
by G. Lienhard, Dartmouth University. All other chemicals were reagent grade and used 
without further purification. 
(b) pH vneaaurements 
All measurements were made at room temperature using a Radiometer pH M-26 
equipped with a combined glass electrode. 
(c) Nw,&ar magmdc reaonarm spectra 
Proton n.m.r. spectra were taken at 220 MHz with a Varian Associates HR220 n.m.r. 
spectrometer. The magnetic fields for the resonances am reported in terms of parts per 
million (p.p.m.) downfield from the fields required for the resonance of DSS (F&2-dimethyl- 
2-eilapentane-K-sulfonate). Temperature was maintained constant to f 1 deg. C with 
the Varian variable temperature accessory. The n.m.r. radio frequency power was 40 db 
(ethyl benzene quartet begins to saturate between 14 and 16 db) and the audio frequency 
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response was 4 Hz. To improve signal-to-noise all spectra were an average of 250 to 500 
scans at 50 ms per channel using a Fabri-Tek 1024 computer. The pH of each sample 
was measured before and after each run. Only those data in which the pH drift was 
less than ItO. pH unit were used. 
3. Results 
(it) Injluence of substrate adogues and non-competitive inhibitors on the His-Asp 
proton resonance 
Chymotrypsin-boronic acid complexes 
Figure 1 shows the low field resonance in chymotrypsinogen A at pH 9.5 as a 
function of the borate salt concentration. It is clear that the resonance is shifted 
to lower field in the presence of borate. Identical behavior for this resonance in 
Chymotrypsinogen t borate 
Afl o.om 
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- 16 -15 -14 [borate] 
S (p.pm) 
FIG. 1. 220 MHz proton n.m.r. spectra of chymotrypsinogen A and various concentretiona of 
sodium borate. The experiments were carried out at 4”C, pH 9.5, in 0.6 M-sodium cmbonate 
[E] = 3.6 X 1W3 M/l. 









-15 -14 [borate] 
FIG. 2. 220 MHz proton n.m.r. speotm of ohymotrypsin & end vwious concentretions of 
sodium borate. [E] = 2.9 x 1OM3 M/L The temperature, pH end carbonate concentrations are aa 
stated in Fig. 1. 
chymotrypsin Ad is seen in Figure 2. In the absence of borate the resonances are 
located at - 15.0 p.p.m. and -14.9 p.p.m. for chymotrypsinogen A and chymotrypsin 
Ad, respectively. At high borate concentrations these resonances disappear and new 
peaks appear at -16.0 and -159 p,p.m. At intermediate borate concentrations, 
both peaks are present. The observed effect is specific to borate ion and not to ionic 
strength because no shifts were observed when Tris or carbonate salts were used in 
place of borate. Furthermore, neither Tris or carbonate prevented the borate induced 
shift when chymotrypsin-borate complexes are measured in the presence of these 
salts. 
Since borate ions presumably bind to many locations on the enzyme molecule, it 
is possible that the observed shift results from binding somewhere other than at the 
active site region. This possibility, however, has been eliminated by a study of the 
effect of borate on the field position of the His-Asp proton resonance in the alkylated 
derivatives Tos-PheCH,Cl-chymotrypsin Ad and z-Gly, Leu, Phe-chymotrypsin Ad 
(Robillard & Shulman, 1974). The resonance field position is unaffected by borate 
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ions up to O-5 M at pH 9.5 in these derivatives, while in the native enzyme molecule 
0.1 M-borate ion is sufficient to shift the same resonance to lower fields. 
When borate ions are replaced by the more specific boronic acid substrate analogues, 
benzene boronic acid and 2-phenylethyl boronic acid, even more extensive shifts of the 
resonance are observed in chymotrypsin Ad. The results presented in Table 1 show 
that, at pH 9.5 in carbonate buffer, benzene boronic acid shifts the His-Asp proton 
resonance 1.55 p.p.m. to lower fields while 2-phenylethyl boronic acid causes a shift 
of 2.3 p.p.m. in the same direction. Although complexes of borate ion with chymo- 
trypsin Ad and chymotrypsinogen A result in identical shifts, 1-O p.p.m. in each case, 
the more specific substrate analogues induce much smaller shifts in chymotrypsinogen 
than in the active enzyme. 
In both native chymotrypsinogen A and chymotrypsin Aa the His-Asp proton 
resonance shifts approximately 3.0 p.p.m. upon changing pH with the midpoint of 
this titration at pH 7.5 (Robillard t Shulman, 1972,1974). However, in the presence 
of the boronic acid substrate analogues the field position of this resonance is in- 
sensitive to pH. The shift induced upon binding the boronic acids at pH 9.5 remains 
TABLE 1 
Line shifts of the His-Asp hydrogen bonded proton ruonance in chymotrypsinogen A 
and chywwtrypsin A,J in the presence of saturating amounts of inhibitor 
6 (p.p.m., DSS) Enzyme 
-18 -17 -16 -16 -14 
I I I I I 
I 16.0 Chtgen A 


























1*9x lo-’ (b) 
- 
4x 10-5 (c) 
Ki for the inhibitors are taken from the literature: (a) Antonov et al. (1968); (b) Philipp & 
Bender (1971); (c) Koehler & Lienherd (1971). 
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PH 
Fra. 3. Comparison of the pH dependenoe of K, for 2.phenylethyl boronic acid inhibition of 
cbymotrypsin (Koehler & Lienhard, 1971) with the pH dependence of the n.m.r. resonenae field 
position for the oomplex of 2-phenylethyl boronic aoid and chymotrypsin. The inhibitor concen- 
tration in the n.m.r. experiments was 0.076 ~/l end the temperature was maintained at 3°C. 
constant throughout the same pH range in which the inhibitor is strongly bound to 
the enzyme. The lower curve in Figure 3 presents the pH dependence of the binding 
of 2-phenylethyl boronic acid to chymotrypsin Ad (Koehler & Lienhard, 1971). The 
upper half of Figure 3 is a plot of the pH dependence of the n.m.r. shift for the His-Asp 
proton resonance in the s&me boronic acid complex. Under the experimental con- 
ditions the inhibitor concentration, 0.075 M, w&s sufficient to saturate the enzyme 
binding site in the pH region 6 to 9.5. As Figure 3 shows, the n.m.r. shift is inde- 
pendent of pH under these conditions. 
(b) hbtihin BPN’-boronic acid complexes 
As will be evident in the Discussion, the interpretation of the boronic acid-induced 
shifts in chymotrypsin Ad is based, in large part, upon the X-ray, crystallographic 
studies of subtilisin BPN’-boronic acid complexes (Kraut & Birktoft, personal 
communication). The use of subtilisin X-ray data to interpret chymotrypsin n.m.r. 
data might appear to be overworking the concept of homology between the active 
sites of these two enzymes. Therefore experiments similar to those just reported 
were carried out with subtilisin BPN’. The low field proton n.m.r. resonance in 
subtilisin was monitored in the presence of benzene boronic acid and 2-phenylethyl 
boronic acid. In Figure 4 the n.m.r. spectra of these complexes are presented and com- 
pared with the n.m.r. spectra of chymotrypsin complexed with the same substrate 
analogues. Benzene boronic acid and 2-phenylethyl boronic acid induce identical 
chemical shifts for the low field proton resonance in subtilisin. Furthermore the 
chemical shifts in subtilisin are identical to those observed in complexes of chymo- 
trypsin Ad with 2-phenylethyl boronic acid. Figure 5 illustrates the pH dependence 
of the field position of this resonance in the subtilisin-boronic acid complexes. It is 
independent of pH over the range 6 to 8.5 in which the boronic acids are tightly 
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Subtilisin+ BBA 
L/u Subtilisint 2-PEBA 
Cht Ag t BBA 
I 
-19 
I I I I 
-18 -17 -16 -15 
8 (p.p.m.) 
Fro. 4. 220 MHz proton n.m.r. speotra of chymotrypsin Ad and subtilisin BPN’ complexes 
with 2.phenylethyl boronio acid (PEBA) or benzene boronia aaid (BBA) Cht, chymotrypsin. 
Enzyme conoentrations: 3 to 4 nm-benzene boronic acid concentrat,ion: 0.2 M-2-phenylethyl 
boronic a.oid concentration: 0.076 M. Temperature + B”C, pH 8 to 9. 
bound to the enzyme. When compared with the chymotrypsin data in the same 
Figure, the a&me behavior for the inhibitor complexes with both enzymes is evident. 
The similarities in the response of the His-Asp proton in chymotrypsin and subtil- 
isin to the boronic acid substrate analogues, appear to justify using subtilisin X-ray 























FIG. 6. n.m.r. resonance position as a function of pH, (0) Chymotrypsin and benzene boronic 
aid; (A) chymotrypsin and Z-phenylethyl boronic mid; (0) subtilisin and benzene boronic 
acid; (A) subtilisin and 2.phenylethyl boronic aoid. Enzyme and inhibitor oonoentrations were 






I I I 
-18 -17 -,lS 
8 (p.p.m.1 
FIG. 0. 220 MHz n.m.r. spectra of chymotrypsin and N-aetyl-L-tryptophan. Enzyme ooncen- 
tration was 3 to 4 mar. Inhibitor oonoentration was 0.1 M below pH 7.6 and 0.6 M above pH 7.5. 
Temperature w&e 3’C. 
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(c) ChymotyptGn-carboxylic wid complexes 
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The borate and boronate induced shifts of the His-Asp proton resonance seem to 
show that the active site region of the enzyme can be quite sensitive to the presence 
of charged inhibitors. This observation has been tested further by monitoring the 
effect of carboxylic acid inhibitors on the position of the His-Asp proton resonance. 
Johnson & Knowles (1966) have demonstrated, by equilibrium dialysis techniques, 
that N-acetyl-L-tryptophan bound more strongly to the low pH form of chymotrypsin 
Cht Ag pH 3.5 
Cht Ag pH 9.5 
ChtAg+PTI pH4.1 
Cht Ag f PTI pH 6.5 
Cht Agt PTI pH9:4 
PTI 
I I I I I I 
-19 -18 -17 -16 -15 -14 
8 (p.p.m.1 
pH4.1 
FIG. 7. 220 MHz n.m.r. spectra of ahymotrypsin 4 (Cht), bovine pancreatic trypsin inhibitor 
and chymotrypsin AcPTI complexes. ‘hmpereture was 3°C. Chymotrypsin concentration wes 
3 to 4 mM. Pancreetia trypsin inhibitor concentration was 3 to 4 mm. Chymotrypsin-PTI complex 
concentration wa8 ~3 mM. The complex w~i&5 prepared by dissolving 10 mg PTI in 0.25 ml of 
water (pH 4) followed by 25 mg ohymotrypsin &. 
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A, than to the high pH form. A k, of -2 mM was measured between pH 2.2 and 7 
while a value of ~14 to 24 mM wss observed between pH 8 and 8.3. The binding 
therefore was dependent on s, group ionizing with a pK, of 7.3. We have measured 
the n.m.r. field position of the His-Asp proton resonance in chymotrypsin under 
conditions where the active site was saturated with N-acetyl-L-tryptophan (i.e. 
0.1 M in N-acetyl-L-tryptophan from pH 5.5 to 7.5 and 0.5 M from pH 7.5 to 8.5). 
The spectra are presented in Figure 6. Under these conditions the resonance field 
position is -17.5 p.p.m. and it remains constant across the pH range 5.4 to 8.5. 
This pH independence is similar to that observed in the chymotrypsin and subtilisin 
boronate complexes. 
(d) Chymot ypain-t ypsin inhibitor complex 
The X-r&y crystal structure and the chemical studies on chymotrypsin and sub- 
tilisin boronic acid complexes have demonstrated that the boronic acids are present 
at the active site as stable tetrahedral adducts of boronate anions (Kraut & Birktoft, 
personal communication; Koehler & Lienhard, 1971). When bovine pancreatic trypsin 
inhibitor (PTI) is complexed with chymotrypsin the X-ray crystallographic data 
suggest that s, similar stable tetrahedral adduct is formed (Riihlmann et a.!., 1973). 
In this case the tetrahedral geometry occurs about the carbonyl carbon of Lysl51 
which is in a covalent bond with Ser195 of chym0trypsin.t Because of the rather 
striking response of the His-Asp proton resonance to the presence of the bound 
boronic acids, the resonance was also monitored in complexes of chymotrypsin plus 
PTI. The spectra of these complexes at three different pH values are compared, in 
Figure 7, with spectra of free chymotrypsin A0 and free PTI. The n.m.r. spectra of 
the complexes show a resonance in the low field region at -14,9 p.p.m. which again 
is invariant with pH. The resonance is not present in free PTI but it is present at an 
identical field position in free chymotrypsin Aa at high pH. 
4. Discussion 
It has been demonstrated by kinetic methods that the chymotrypsin-catalyzed 
hydrolysis of amides and peptides proceeds via a tetrahedral intermediate species of 
the substrate just 8s in the hydrolysis of amides in solution (Jencks, 1969; Fersht, 1971; 
Fersht & Requene, 1971; Caplow, 1969; Lucas et al., 1973). The kinetic data for the 
existence of this intermediate has been supported by X-ray crystallographic in- 
vestigations showing structural features at the active sites of chymotrypsin and 
subtilisin BPN’ which could stabilize such an intermediate (Henderson et al., 1971; 
Henderson, 1970; Robertus et al., 1972). Whether such an intermediate is stable 
enough to accumulate is still in contention. Nevertheless, it is obvious that the 
placement of such a charged species at the active site, with its rather rigid stereo- 
chemical requirements, may have a profound effect on the state of protonetion of 
the amino acid side chains directly involved in the catalytic process. One way to 
study this intermediate catalytic state in detail is to use stable tetrahedral transition 
state analogues. Orgenoboron compounds as well as borate itself can exist in either 
of two general configurations. In one the boron atom is trigonal coplanar with sp2 
hybridization, having empty 2p orbitals above and below the BO, plane. Thus, 
t Amino acid residues of panoreetic trypsin inhibitor are designated by I. 
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Iha. 8. &hem&o representation of the aative site region of chymotrypsin complexed with 
boron&e inhibitors. The inform&ion presented here is e combination of n.m.r. date end X-ray 
crystallographic data from subtilisin-boronate complexes provided by I&& & Birktoft (personal 
communication). 
being electron deficient the boron is capable of adding a, fourth ligand and converting 
to the second con@uration which is tetrahedral with sp3 hybridization (Gerrard, 
1961; Edwards et CL!., 1956). Because of this ability to form stable tetrahedral adducts 
Koehler & Lienhard (1971) examined the boronic acids as possible analoguea of the 
tetrahedral transition state and suggested that their kinetic data on 2-phenylethyl 
boronic acid could be explained by the formation of a tetrahedral adduct. Complexes 
of 2-phenylethyl boronic acid and benzene boronic acid with subtilisin BPN’ have 
been shown by recent X-ray crystallographic studies to exist as the tetrahedral 
adduct (Kraut & Birktoft, personal communication). The boron is covalently 
attached to the active site serine while one of its oxygens is hydrogen bonded to 
backbone amide groups in the “oxy-enion hole” and the other oxygen is hydrogen 
bonded to N(3) nitrogen of the active site histidine as shown schematically in Figure 8. 
We propose that the n.m.r. studies of the boron complexes in both chymotrypsin 
and subtilisin can be interpreted in terms of this structure and that the n.m.r. shifts 
can be used to understand charge distribution within the complex. It should be noted 
that the X-ray studies were done on the boronic acid inhibitors and not on borate 
itself. It is possible that borate could bind covalently to the hiatidine. However 
because of the arguments presented in Section (b)(3) of the Discussion we feel that 
the X-ray data on the boronic acid inhibitors describe the structure of the borate- 
enzyme complex as well. 
(a,) Origin of the inhibitor induced nudear rrwnetti resonance sh@ts 
The discrete shift in the His-Asp proton resonance with borate suggests that the 
borate reaction with the enzyme is slow on the n.m.r. time scale. This means that the 
lifetime of the borate-chymotrypsin Ad and borate-chymotrypsinogen A complexes 
are long compared to the linewidths, i.e. 7 >> (~Sv)-l or 7 >> 3 x 10m3 seconds. If the 
reaction is represented as a simple equilibrium 
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then the equilibrium constant is 
K = MB1 k,, 
[EBI = c2 . 
Since intermediate borate concentrations show no additional broadening of the 
enzyme and zymogen NH resonances (pigs 1 and 2) we conclude that the forward 
rate of borate is not fast enough to broaden the lines. Hence 
1 aI31 --= 
[El, at 
kl,[B], = i < &v 
7 
or 
k,, <3X104 M-l 18-l 
for a free borate concentration of [B], m 0.01 M, and 6v ~10~ Hz. The rate of forma- 
tion of simple enzyme-inhibitor complexes occurs orders of magnitude faster (k,, for 
the reaction of proflavin with chymotrypsin A, is M lOa M-I 1 s-l (Havsteen, 1967)). 
Therefore this rather slow rate of borate binding is consistent with the formation 
of a covalently bound complex to the enzyme. The total concentrations of enzyme 
and borate are known and [E] and [EB] can be determined from the areas under the 
two resonance peaks. Hence the apparent equilibrium constants for the borate 
complexes can be determined. At pH 9.5 in O-5 M-sodium carbonate we calculate that 
k equals 1.3 x lOpa ~/l and 5.6 x 10T2 ~/l for the borate-chymotrypsinogen and 
borate-chymotrypsin Aa complexes, respectively. The value for chymotrypsin A,J 
is within a factor of two of the inhibition constant, k,, for chymotrypsin A,, 1 x 10-l 
~/l, determined by competitive inhibition studies (Antonov et al., 1970). The binding 
constant to chymotrypsinogen has not been reported. 
Three lines of evidence in the above experiments demonstrate that the shifts 
induced by borate and the boronic acids result from a direct interaction with the 
active site region. 
(1) The downfield shifts observed with the active enzyme-inhibitor complexes 
increase monotonically with the inhibition constants determined by competitive 
inhibition measurements (see Table 1). 
(2) The equilibrium constant determined from the n.m.r. measurements of the 
borate-chymotrypsin Ad complex is within a factor of two of the inhibition constant 
in chymotrypsin A, measured by competitive inhibition. 
(3) In derivatives of chymotrypsin Ad which have been alkylated at the N(3) 
position of His57, the His-Asp proton resonance is not shifted by borate. This 
indiuates that borate competes for the region occupied by part of the alkylating 
group. 
(b) The variation in the nuclear magnetic resonance shifts 
Having established that the shifts of the His-Asp proton resonance arise via a 
direct interaction of the boronates with the active site region, it is now necessary 
to consider the possible mechanisms which would generate a different chemical 
shift for each inhibitor studied. There are three such mechanisms. 
(1) A conformational change could result upon binding boronates which would 
perturb the active site residues so as to cause the observed shifts. Such an explanation 
is unlikely since it would necessitate five different conformational changes, or, at 
STUDIES OF THE ACTIVE SITE OF CHYMOTRYPSIN. II 553 
least, five different degrees of a single conformational change, in chymotrypsin and 
chymotrypsinogen. 
(2) The different chemical shift for each enzyme-inhibitor complex could be a 
function of the electronic charge on the inhibitor. This alternative is likewise un- 
acceptable since the pK, values for the ionization of the inhibitors, which are a 
measure of their charge, vary in a different order from the inhibitor-induced change in 
chemical shift (Yabroff et d., 1934). Furthermore, if charge distribution was the 
principal mechanism for the variation in the chemical shifts one would expect to 
observe the same shift for each inhibitor whether bound to chymotrypsin Ad or to 
chymotrypsinogen A and this is not the case. 
(3) The most probable mechanism of these shifts includes both the rigid stereo- 
chemical requirements of the active site region and the electronic structure of the 
tetrahedral complex. When an aromatic binding site is not required to bind the 
inhibitor, as in the case of borate, the inhibitor-induced shift is the same for chymo- 
trypsinogen and chymotrypsin Ad complexes. In this case the borate ion is pre- 
sumably free to take the optimum position for the bond and the observed shift 
depends only upon the electronic nature of borate. However, when the inhibitor 
possesses an aromatic moiety and becomes more like a substrate, as witnessed by 
the decrease in k,, progressively larger shifts occur in the active enzyme, but smaller 
shifts occur in chymotrypsinogen which lacks most of the substrate binding site 
(Freer et al., 1970). Thus, the difference in orientation of the inhibitor with respect to 
the active site residues is responsible for the difference in the chemical shifts observed 
in these complexes. 
This combined effect of structure and electronic properties upon the resonance is 
observed in the n.m.r. data of the subtilisin BPN’-boronic acid complexes (Figs 4 
and 5). The His-Asp proton resonance in subtilisin is shifted to the identical position 
in both the 2-phenylethyl boronic acid and benzene boronic acid complexes. In 
keeping with this observation, the X-ray crystallographic studies of the subtilisin- 
boronic acid complexes show that these two boronic acids occupy identical positions 
at the active site (Kraut & Birktoft, personal communication). Therefore, when the 
orientations of the inhibitors are the same, the n.m.r. resonance positions in the 
complexes are the same. This leads us to predict that in chymotrypsin Aa these two 
boronic acid complexes will have slightly different, structures. 
(c) Interpretation of the nuclear magnetic resonance shifts 
Johnson & Knowles (1966) have demonstrated that neutral inhibitors such as 
N-acetyl-n-tryptophan amide bind to chymotrypsin independently of pH over the 
range pH 2.2 to 9.6. On the other hand the binding of negatively charged inhibitors, 
such as N-acetyl-n- or L-tryptophan, depended on the ionization of a group in the 
free enzyme with a pK, of ~7.3. Therefore they suggested that the active site of the 
free enzyme carried a net charge of -1 at pH > 7.5. This interpretation is con- 
sistent with the n.m.r. data and with the structure shown in Figure 9. Fersht & 
Sperling (1973) have shown that a residue with a pK < 3, becomes exposed and 
protonates upon denaturation at pH > 3. This too is consistent with Figure 9 since, 
upon denaturation, the individual residues become available for protonation which 
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Fro. 9. Sohemetic representation of the active site region of ahymotrypsin at low and high pH. 
for 3 < pH < 6 should result in one additional proton binding site. Turning to the 
boronate binding Koehler & Lienhard (1971) observed the same type of pH depen- 
dence for the binding of 2-phenylethyl boronic acid to chymotrypsin as Johnson & 
Knowles (1966) observed, but with a slightly lower PK. They proposed that a net 
charge of - 1 was carried in the active site region of the boronate+nzyme complex. 
Their preferred structure for this complex, which is supported by the recent X-ray 
crystal structure (Kraut & Birktoft, personal communication) is shown in Figure 8. 
These observations require that the boronic acid raises the pK of the His-Asp region so 
that in the boronate complex there is s proton at the N(3) of His57, which is pre- 
sumably held there by a hydrogen bond. This is consistent with the observations 
that the positions for the His-Asp proton resonance in the chymotrypsin-boronate 
complex are independent of pH as shown in Figures 3 and 5 and by the positions of 
the resonance (see Table 1) which are intermediate between those observed for the 
high and low pH forms of the enzyme (cf. accompanying paper). These intermediate 
positions presumably reflect the charge perturbation on the imidezole ring arising 
from different interactions of the boronate oxygens with the N(3) of His57 through 
the hydrogen bond (Fig. 8). It is our assumption that the field position of the His-Asp 
proton resonance reflects this charge perturbation based upon the results on the 
unmodified enzyme where the resonance shifts from -150 to -l&O p.p.m. as the 
pH is lowered. 
With these assumptions we can interpret the present data so as to give qualitative 
information about the position of the proton in the N(3) His-borate hydrogen bond. 
In the borate complexes the resonance position of -16.0 p.p.m. suggests that the 
N(3) proton is fairly close to the borate oxygen, possibly reflecting the greater attrac- 
tion of the borate for a proton. In the strongly bound 2-phenylethyl boronic acid 
the resonance position of -17.2 p.p.m. indicates that the proton has moved closer 
to His57, presumably because the bond is weakened by the constraints placed upon 
the inhibitor’s position by the aromatic binding pocket. 
While borate and boronate anions form covalent complexes at the active site and 
undergo a change in the hybridization state of the boron, carboxylste anions do not. 
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It is known from the X-ray crystallographic studies thet N-formyl-L-tryptophan 
and N-formyl-L-phenylalanine form non-covalent complexes with the active site of 
the enzyme and maintain a trigonal configuration about the carboxylate carbon. 
Nevertheless, in these complexes also one of the carboxylate oxygens is hydrogen 
bonded to the N(3) nitrogen of His57 (Steitz et al., 1969). This is consistent with the 
data of Johnson & Knowles (1966) which demonstrates that the carboxylate anion 
of N-acetyl-L-tryptophan has B stronger a0inity for the low pH form of the enzyme. 
Apparently a charge-charge interaction between imidazolium ion and the anionic 
inhibitor ss shown in scheme 1 accounts for a substantial portion of the low pH 
aftlnity. 
Scheme 1 
Since this system is quite analogous to that presented in Figure 8 for the enzyme- 
boronic acid complexes, one would predict a similar response of the His-Asp proton 
resonrtnce to the presence of N-acetyl-Mryptophan. The field position of this 
resonance (-175 p.p.m.) and its invariance with pH as shown in Figure 6 confirm 
these predictions. From the calibration used for the boronic acid complexes, the 
resonance field position being close to -18.0 p.p.m. suggests that the histidine is 
close to the fully proton&d state, but that it is not fully proton&$ presumably 
because of a hydrogen bond to the carboxylate. 
(d) The traneitim state 
The bond-making and bond-breaking steps occurring in the transition state are 
accompanied by proton transfer from His57 to the leaving group of the substrate. 
In both the boronic acid and carboxylic acid chymotrypsin complexes we have 
demonstrated a direct interaction between the atom occupying a position analogous 
to the leaving group of a normal substrate and the proton at the N(3) position of 




One important conclusion from the present experiments is that, in these tetrtthedral 
complexes, His57 csn be maintained at intermediate degrees of proton&ion as 
demonstrated by the intermedi&..e field positions of the His-Asp proton resonance. 
This is in contrast to normal imidszole in solution which is either proton&d or not, 
and shows no intermediate degrees of proton&ion. The ability of the histidine to 
assume intermediate degrees of protonation in these complexes suggests that in the 
tetrahedral state there may be an unusually shallow potential energy well for the 
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proton between the N(3) of His57 and the amide nitrogen of the substrate leaving 
group. It has been calculated (Merlet et al., 1972) for the [H,N-H. . .NH,]+ system 
that when the distance between the heavy atoms is reduced, the potential energy 
barrier is decreased and eventually disappears. Furthermore the energy cost to 
eliminate this barrier and create just a single broad potential minimum is only 
2.9 kcal. Therefore we suggest that upon formation of the tetrahedral intermediate 
the two hydrogen bonds formed between the substrate and the enzyme in the oxy- 
anion hole could provide the energy necessary to move the leaving group nitrogen 
close enough to the histidine so that the potential well of the N(3) proton between 
His57 and the leaving group nitrogen is made shallower, possibly going to a single 
minimum. Certainly the borate experiments demonstrate a dependence of the hydro- 
gen bond potential upon binding of the aromatic moiety of the substrate. The variety 
of proton positions observed in the boronate complexes is more consistent with a 
shallow minimum than with the deep double minimum potential model of a normal 
hydrogen bond. This minimization of the potential energy barrier for proton transfer 
leads to a further understanding of the catalysis if the reaction proceeds via a con- 
certed mechanism. In this case, first the substrate carbonyl approaches the serine and 
bond formation occurs with the carbonyl carbon assuming a tetrahedral geometry. 
Then we suggest that hydrogen bonds which form in the oxy-anion hole provide the 
energy required to push the leaving group nitrogen close enough to N(3) of His57. 
With the potential energy barrier for proton transfer to the leaving group minimized 
by this process, protonation of the leaving group nitrogen occurs in concert with 
peptide bond cleavage, and this rate limiting step is catalyzed by the accommodating 
nature of the hydrogen bonded proton. 
These present experiments suggest that the function of the buried aspartate is to 
increase the polarizability of His57 so that together they serve as a charge reservoir, 
facilitating the uptake and release of protons during the catalytic process. 
(e) Chymotypsin-pancreatic t ypsin inhibitor complexes 
Finkenstadt & Laskowski (1965) have shown that chymotrypsin displays limited 
enzymatic activity towards the trypsin inhibitor molecule and proposed that the 
enzyme forms either a stable acyl intermediate or tetrahedral intermediate with the 
inhibitor. The recent X-ray data of Riihlmann et al. (1973) on the trypsin-PTI 
complex indicates that it is the tetrahedral species which is formed. Furthermore 
Riihlmann et al. (1973) also observed that the histidine is close enough to the serine 
oxygen to be hydrogen bonded, and used this observation to explain the stability 
of the tetrahedral adduct. In this view the hydrogen bond between the N(3) nitrogen 
of His57 and the serine oxygen stabilizes the tetrahedral adduct by preventing its 
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Scheme 3 
However, after refinement of the X-ray crystal structure of the bovine trypsin-PTI 
complex Huber et al. (1973) reported a distance of 2.3 A between the oxygen of Ser195 
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and the carbonyl carbon of Lysl51. This distance does not correspond to a true 
covalent bond distance which is M 1.5 A. While Huber et al. (1973) realize the possi- 
bility that the value of 2.3 A could reflect a bimodal distance distribution between 
1.5 A and 3.0 tf with 2.3 A being the mean value, they do not observe this distribution 
of electron density in their maps and therefore they prefer a single complex represented 
by a bond distance of 2.3 b. The n.m.r. magnetic field position of the His-Asp proton 
resonance in the chymotrypsin-PTI complex differs from what would be predicted 
on the basis of scheme 3 where His57 is protonated and the resonance should occur 
between -17 and -18 p.p.m. as it does in the native enzyme at low pH. Instead in 
the complex the resonance occurs at -14.9 p.p.m. across the pH range 4 to 9.4 (Pig. 7) 
which is identical to that observed in the native enzyme at high pH where His57 is not 
protonated but hydrogen bonded to Ser195 (Robillard t Shulman, 1974). Thus, in 
light of the apparent uncertainty concerning whether or not the covalent bond is 
actually formed between Ser195 and the inhibitor, the n.mr. data suggests that it is 
not. This interpretation of the n.m.r. results is further supported by recent findings of 
Lazdunski (personal communication) on the anhydrotrypsin-PTI complex. In those 
studies the active site serine of trypsin is converted to dehydroalanine thus preventing 
covalent bond formation with the inhibitor. Comparisons of the binding constant and 
the association and dissociation rate constants for the interaction of native or anhydro- 
trypsin with both native and reduced PTI show only very slight differences between 
native and modified trypsin suggesting that the active site serine plays very little, if 
any role in the stabilization of the enzyme inhibitor complex. 
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